|

Electronic Health Record Augmented LDL-Cholesterol Optimization and Control Via Active Lipid Engagement (EHR-LOCALE): A Quality Improvement Implementation Study

RECRUITINGN/ASponsored by University of Alberta
Actively Recruiting
PhaseN/A
SponsorUniversity of Alberta
Started2026-08-10
Est. completion2027-09
Eligibility
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07685639

Summary

The purpose of this study is to determine whether a proactive, EHR-guided approach helps more individuals reach safe cholesterol levels, improves medication use, and reduces future heart attacks and strokes, compared to usual care. The main question it aims to answer is: • Does the EHR-LOCALE pathway increases the proportion of patients who reach the LDL-cholesterol target of \<1.8 mmol/L at 6 months? Participants in the interventional group receive: * Pharmacist contact * Repeat lipid requisitions * Review of medications, adherence, and side effects * Treatment escalation according to national dyslipidemia guidelines

Eligibility

Healthy volunteers accepted
Inclusion Criteria:

1. Adults over the age of 18
2. Resident of Alberta
3. Individuals hospitalized with an acute coronary syndrome and have undergone coronary angiography.
4. Able to participate in follow-up contact if randomized to the intervention arm

Exclusion Criteria:

1\. In-hospital mortality

Conditions5

ACS - Acute Coronary SyndromeDyslipidemiaHeart DiseaseHyperlipidemiaLow-Density-Lipoprotein-cholesterol Level

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.